We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
901
Slow Capital
California
$3.2M -$42.7K -91 -1%
BO
902
Bank OZK
Arkansas
$3.19M -$2.34K -5 -0.1%
Lido Advisors
903
Lido Advisors
California
$3.19M -$521K -1,111 -14%
MSRPS
904
Maryland State Retirement & Pension System
Maryland
$3.18M +$3M +6,404 New
BSW
905
Buckingham Strategic Wealth
Missouri
$3.17M +$2.51M +5,355 +368%
SGM
906
Skye Global Management
Florida
$3.17M +$1.97M +4,200 +162%
FI
907
FormulaFolio Investments
Michigan
$3.17M +$1.01M +2,160 +47%
WS
908
Wedbush Securities
California
$3.16M +$324K +692 +11%
DR
909
Davis Rea
Ontario, Canada
$3.16M +$79.7K +170 +3%
Koshinski Asset Management
910
Koshinski Asset Management
Illinois
$3.15M +$599K +1,277 +23%
CPIA
911
Cornell Pochily Investment Advisors
New York
$3.14M -$18.8K -40 -0.6%
FRA
912
Front Row Advisors
California
$3.13M -$21.1K -45 -0.7%
IIM
913
Ipswich Investment Management
Massachusetts
$3.12M +$77.4K +165 +3%
KC
914
Kingfisher Capital
North Carolina
$3.12M +$252K +537 +9%
CIC
915
Chase Investment Counsel
Virginia
$3.12M +$1.8M +3,848 +135%
Rafferty Asset Management
916
Rafferty Asset Management
New York
$3.09M -$246K -524 -7%
EHWM
917
Eads & Heald Wealth Management
Georgia
$3.08M -$196K -418 -6%
APWM
918
Atlas Private Wealth Management
New York
$3.06M -$109K -233 -3%
ACA
919
Aptus Capital Advisors
Alabama
$3.06M +$444K +948 +17%
EBT
920
Enterprise Bank & Trust
Massachusetts
$3.05M -$138K -294 -4%
NFC
921
Northeast Financial Consultants
Connecticut
$3.05M -$120K -255 -4%
DWM
922
Darwin Wealth Management
Florida
$3.04M +$2.76M +5,896 +924%
SAM
923
Sawgrass Asset Management
Florida
$3.04M -$359K -765 -11%
AO
924
Advisor OS
Illinois
$3.04M +$1.54M +3,288 +102%
CS
925
Comerica Securities
Michigan
$3.03M -$10.8K -23 -0.4%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.